ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 883,85
-0,29%
Dow Jones
44 556,04
0,30%
DAX
21 412,60
-0,46%
Brent Oil
75,535
-0,53%
Bitcoin
97 935,81
0,08%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV

  6. Rakovina Therapeutics Inc (RKV) Cours

Rakovina Therapeutics Inc

Rakovina Therapeutics Inc (RKV)

TSXV
0,215
0,025
(13,16%)
Fermé 05 Février 10:00PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,215
Prix Achat
0,205
Prix Vente
0,215
Volume échangé
368 838
0,18 Fourchette du Jour 0,22
0,005 Plage de 52 semaines 0,23
Cap du marché
15,068M
Clôture Veille
0,19
Ouverture
0,19
Dernière Transaction
1000
@
0.215
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
300 125
Actions en circulation
70 084 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-5,36
Bénéfice par action (BPA)
-0,04
Chiffre d'affairess
-
Bénéfice net
-2,61M

À propos de Rakovina Therapeutics Inc

Secteur
Unit Inv Tr, Closed-end Mgmt
Industrie
Unit Inv Tr, Closed-end Mgmt
Site Web
www.rakovinatherapeutics.com
Siège social
Vancouver, British Columbia, Can
Fondé
-
Rakovina Therapeutics Inc est coté dans le secteur Unit Inv Tr, Closed-end Mgmt de la TSX Venture Exchange avec le ticker RKV. Le dernier cours de clôture d'Rakovina Therapeutics était de $0,19. Au cours de la dernière année, les actions de Rakovina Therapeutics ont été négociées dans une fourchette de prix de $ 0,005 à $ 0,23.

Rakovina Therapeutics compte actuellement 70 084 000 actions en circulation. La capitalisation boursière d'Rakovina Therapeutics est de $13,32 million. Rakovina Therapeutics a un ratio cours/bénéfice (ratio PE) de -5.36.

RKV Dernières nouvelles

Plus de nouvelles

Rakovina Therapeutics Announces Listing on Frankfurt Stock Exchange

VANCOUVER, British Columbia, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company dedicated to advancing new cancer therapies based on novel...

30 Janvier 2025
GlobeNewswire Inc.

Rakovina Therapeutics to Participate in BioInnovate UBC Annual Conference

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company advancing innovative cancer therapies through artificial...

29 Janvier 2025
GlobeNewswire Inc.

Rakovina Therapeutics Comments on $500 Billion AI Infrastructure Investment and Its Implications for Healthcare Innovation

VANCOUVER, British Columbia, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company at the forefront of AI-driven drug discovery, yesterday...

22 Janvier 2025
GlobeNewswire Inc.

Rakovina Therapeutics Announces Key Milestone in Cancer Drug Innovation in Collaboration with Variational AI

VANCOUVER, British Columbia, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company dedicated to advancing new cancer therapies based on novel...

13 Janvier 2025
GlobeNewswire Inc.

Rakovina Therapeutics Announces Receipt of AI-Derived Drug Candidates and Advancement to Preclinical Validation

VANCOUVER, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company focused on the development of new cancer therapies based on...

06 Janvier 2025
GlobeNewswire Inc.

Rakovina Therapeutics to Connect with Industry Leaders During 43rd Annual J.P. Morgan Healthcare Conference Week

VANCOUVER, British Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics, Inc. (TSX: RKV), a biopharmaceutical company focused on the development of new cancer therapies based on...

03 Janvier 2025
GlobeNewswire Inc.

Rakovina Therapeutics: Reflecting on 2024 Success and Building Momentum for a Transformative 2025

VANCOUVER, British Columbia, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) a biopharmaceutical company focused on the development of new...

19 Décembre 2024
GlobeNewswire Inc.

Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations

VANCOUVER, British Columbia, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) announces that in accordance with the terms of an indenture...

18 Décembre 2024
GlobeNewswire Inc.

Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement

VANCOUVER, British Columbia, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”, “Rakovina”, or “Rakovina Therapeutics”) a biopharmaceutical company...

14 Décembre 2024
GlobeNewswire Inc.

Rakovina Therapeutics Announces Presentation at the 13th Annual Tumour Models London Summit

VANCOUVER, British Columbia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical company committed to advancing new...

03 Décembre 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.014.878048780490.2050.220.171900920.19359258CS
40.02513.15789473680.190.230.153270750.20018604CS
120.135168.750.080.230.0453001250.14731098CS
260.12126.3157894740.0950.230.0451684760.13586911CS
520.125138.8888888890.090.230.0051093560.12573508CS
1560.02513.15789473680.190.250.005465040.12952478CS
260-0.035-140.250.3950.005460670.14432885CS

RKV - Frequently Asked Questions (FAQ)

What is the current Rakovina Therapeutics share price?
The current share price of Rakovina Therapeutics is $ 0,215
How many Rakovina Therapeutics shares are in issue?
Rakovina Therapeutics has 70 084 000 shares in issue
What is the market cap of Rakovina Therapeutics?
The market capitalisation of Rakovina Therapeutics is CAD 13,32M
What is the 1 year trading range for Rakovina Therapeutics share price?
Rakovina Therapeutics has traded in the range of $ 0,005 to $ 0,23 during the past year
What is the PE ratio of Rakovina Therapeutics?
The price to earnings ratio of Rakovina Therapeutics is -5,36
What is the reporting currency for Rakovina Therapeutics?
Rakovina Therapeutics reports financial results in CAD
What is the latest annual profit for Rakovina Therapeutics?
The latest annual profit of Rakovina Therapeutics is CAD -2,61M
What is the registered address of Rakovina Therapeutics?
The registered address for Rakovina Therapeutics is 720,999 WEST BROADWAY, VANCOUVER, BRITISH COLUMBIA, V5Z1K5
What is the Rakovina Therapeutics website address?
The website address for Rakovina Therapeutics is www.rakovinatherapeutics.com
Which industry sector does Rakovina Therapeutics operate in?
Rakovina Therapeutics operates in the UNIT INV TR, CLOSED-END MGMT sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ROCKEros Resources Corp
 0,06
(300,00%)
644,88k
NICKNickelex Resource Corporation
$ 0,01
(100,00%)
161k
TVITVI Pacific Inc
$ 0,01
(100,00%)
150k
PORPortofino Resources Inc
$ 0,01
(100,00%)
240k
FUNDKatipult Technology Corp
$ 0,01
(100,00%)
20k
DMDataMetrex AI Limited
$ 0,005
(-50,00%)
2,18M
NZPChatham Rock Phosphate Limited
$ 0,055
(-35,29%)
9k
CCDCascadero Copper Corporation
$ 0,01
(-33,33%)
4k
HBKHighbank Resources Ltd
$ 0,01
(-33,33%)
35k
SCLTSearchlight Resources Inc
$ 0,01
(-33,33%)
242k
WGOWhite Gold Corp
$ 0,20
(17,65%)
11,26M
GPUSAlset AI Ventures Inc
$ 0,115
(15,00%)
4,47M
OMIOrosur Mining Inc
$ 0,19
(65,22%)
4,45M
BRCBlackrock Silver Corp
$ 0,355
(9,23%)
2,48M
XBOTRealbotix Corp
$ 0,48
(-4,00%)
2,41M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

TSXV
RKV
Rakovina Therapeutics
LSE
BNR
Burning Rock Biotech
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces